Our fund advanced 24.8% net in November, taking us to +92% net for the calendar year-to-date. Since inception we have compounded at 28% net pa, over a period which included two fierce bear markets and several sharp shifts in policy and economic conditions.
This compares favourably with market indices. For every $1 the ASX 200 Total Return has generated, for example, we have made well over $4 net.
For another touchpoint, we have now outperformed the ASX200 Total Return by >20% on an annualized basis.
These returns have been broad based: we currently hold ~40 investments and all of our current positions are under 7%. It is one thing to generate returns like this with four positions, quite another with forty.
It’s fashionable in some tech investing circles to run highly concentrated portfolios. We’ve been sympathetic to that approach in the past, but think a broader portfolio is better, as it ensures we capture the explosive organic growth of our companies without overexposure to any one name.
We know that for many of our investors, we are their only exposure to these companies, and there’s something inherently unpredictable about which of our companies will perform best at any one time.
Perhaps the best risk/reward in finance is found in a 3-4% position in a fast-growing company. The downside is 1-2%, but a high performer can easily add >25% across an entire portfolio.
With 2%-4% positions it’s also straightforward to add to companies that have temporarily sold off, and to sell a company that no longer displays the explosive growth and customer love we find so useful as a guide.
Given the rapid explosion in technological adoption this year, we don’t think we’re going to run out of opportunities any time soon.
The 21st century started in 2020
This is attributed to Peter Thiel and we couldn’t agree more.
For all the trials and tragedies of 2020, this was a year when all kinds of technology accelerated.
In 2020 the use of hydrogen in transportation reached critical levels, much to the benefit of Plug Power (6x), whose fuel cells now transport ~30% of US retail food and groceries.
It was also a good year for space, with Virgin Galactic (which we own) and SpaceX (which sadly we can’t) both laying down serious milestones in what will be one of the future’s largest industries.
Biology has always had data at its core, but in 2020 this data science reached new heights. Chinese scientists posted the genetic code of the coronavirus online, and within days the Moderna developed the first of what will likely be many mRNA vaccines without any access to the virus itself. Truly science fiction stuff.
Fortunes were invested in biological research this year, and it has never been cooler to be a biological scientist. Talent and capital is a thrilling combination. The next decade should be a good one for the life sciences.
We’ll always position our fund at the forefront of technological shifts. It’s often uncomfortable on the front lines. Balance sheets and income statements are messy, and the extraordinarily talented people that build new businesses are often odd.
But it’s far riskier, in our opinion, to be on the other side of these shifts. Simply look at the performance of Tesla and Carvana versus the auto industry, Afterpay and Square versus global banks, and Shopify, MercadoLibre and Sea versus traditional retailers.
Our mid and large cap companies are growing at over 75% pa. In a world of flat to weak GDP growth, this revenue must be coming from somewhere else.
And that somewhere else is where the vast majority of capital is invested – and quite likely most of your own.
This was a year where those taking extraordinary risks to advance the human race were richly rewarded, and for that we can all be thankful.
Rotations and double winners
Readers will know we laid the groundwork for November by reducing our exposure to richly valued software companies (for example) and investing in companies well placed for a recovery.
The best companies right now are double winners with these two characteristics:
1) They’re already growing exceptionally fast, and
2) will also accelerate in a recovery.
This is a tough ask for any one company, but there are indeed some.
Disney is an example we have given before, with an explosively fast-growing consumer business (Disney+) combined with broadly loved theme parks, which used to contribute almost half of Disney’s profit, and will soon do so once more.
Another example is Square, which is already amongst the fastest growers among companies with market capitalization over $100 billion, while also standing to benefit from a return of foot traffic to retail malls.
Square is interesting for another reason.
The holy grail in payments is creating a closed loop, where transactions between customers and merchants all happen within a single ecosystem, effectively on a company database rather than through the archaic payments network.
This would bypass traditional banks, the likes of Mastercard & Visa, and all the other payment layers that plague us (we seem to discover new ones all the time).
A closed loop payment system would allow instant, highly efficient transactions, which is precisely how financial data should flow in the 21st century.
We think Square could be the first to achieve this.
Square began with those familiar smartphone card readers for merchants. But Square also has a rapidly growing cash app in the United States. This now has over 30 million users, up from 15 million last year, and as you know we love growth rates >100%! These users are transacting about 15x per month on average.
So they have two sides of the prized closed loop:
We think the graphic below is interesting not only for what it says about Square, but also how it illustrates what’s going on in financial markets today.
A $32 million investment in Sales and Marketing in Q1 2015 is now generating $172 million of gross profit a quarter.
Imagine a value investor looking at the financial statements in Q1 2015… they will just see that expense as a cash flow drag, a cost with no corresponding balance sheet item. Yet this kind of return is one and perhaps two orders of magnitude greater than what’s achievable from traditional capital expenditures in factories, equipment and the like.
The optimal strategy here is to spend all those subsequent gross profit dollars on even more sales and marketing.
The best guide to 2020 was to focus entirely on companies that were thriving in the prevailing market. E-commerce, digital health, payments, the right life sciences companies – these served us extraordinarily well.
We plan to use the same process to guide us over the next 12 months: we will only invest in companies thriving in the current market conditions. The good news is the kinds of companies that we invest in can thrive for decades, and perhaps generations, like the evolution of hydrogen energy, solar, electric vehicles, advances in genomic sequencing and space.
It’s good to know that even in a year including an astonishingly brutal bear market (which hit us quite hard) we can still net over 90%. The juice has been worth the squeeze.
It wasn’t easy in March… there were more than a few McDonalds-eating Buffett-quoting managers who turned out to be sellers, rather than buyers. And to be fair, a nastier virus could have lead to a more prolonged shock – though this may have led to a stronger policy response, a sharper rally after, and perhaps even greater returns to our holdings in ecommerce, digital health etc.
Finally, a comment on timing.
I had multiple discussions around June/July about timing. Many thought things had run hot, and they had. But as we approach the new year, quite a number of our portfolio companies are already 30-40% larger. And June wasn’t so long ago.
There are people reading this who invested on 1 October 2018, right before the trade war and Jerome Powell’s short lived attempt to raise rates. There are others reading this whose funds were invested on 1 March 2020, moments before one of the sharpest sell-offs in market history.
Both sell-offs hit us hard, and friends of mine will attest I wasn’t exactly the best of company during those months. But when markets really started moving, we proved one of the steadier hands, and were able to take advantage of the opportunities on offer.
Our net IRR includes those sell-offs, as well as the rallies. And even for those who invested at the two worst possible times over the last decade, the fund has performed.
The smart play now is to stay invested in the fastest growing highest quality companies we can find. That was our approach in March, and remains our approach today.
It’s a sad fact that at some point in the future a new turn of events will shake markets to their core. And when that happens, you can rely on us to act in exactly the same way.
A sincere thank you for all your support
The information in this note has been prepared and issued by Frazis Capital Partners Pty Ltd ABN 16 625 521 986 as a corporate authorised representative (CAR No. 1263393) of Frazis Capital Management Pty Ltd ABN 91 638 965 910 AFSL 521445. The Frazis Fund is open to wholesale investors only, as defined in the Corporations Act 2001 (Cth). The Company is not authorised to provide financial product advice to retail clients and information provided does not constitute financial product advice to retail clients.
The information provided is for general information purposes only, and does not take into account the personal circumstances or needs of investors. The Company and its directors or employees or associates will use their endeavours to ensure that the information is accurate as at the time of its publication. Notwithstanding this, the Company excludes any representation or warranty as to the accuracy, reliability, or completeness of the information contained on the company website and published documents.
The past results of the Company’s investment strategy do not necessarily guarantee the future performance or profitability of any investment strategies devised or suggested by the Company.
The Company, and its directors or employees or associates, do not guarantee the performance of any financial product or investment decision made in reliance of any material in this document. The Company does not accept any loss or liability which may be suffered by a reader of this document.